documented baseline AMH levels of 2.8 ng/ml, with a 40% live birth rate per cycle and a 42.1% success rate per embryo transfer among 15 of the 147 cancer patients who proceeded with frozen embryo transfers (27). The gene discussed is AMH; the disease is cancer.